Randomised study of screening for colorectal cancer with faecal-occult-blood test

Lancet

Volumn 348, Issue 9040, 1996, Pages 1467-1471

  Kronborg, Ole ^a   Fenger, Claus ^a   Olsen, Jørn ^b   Jørgensen, Ole Dan ^a   Søndergaard, Ole ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030607609     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)03430-7     Document Type: Article

References (13)

1. 1 Selby JV, Friedman GD, Quesenbury CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Int Med 1993; 118: 1-6.
2. 2 Wahrendorf J, Robra B, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 1993; 2: 221-27.
3. 3 Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-18.
4. 4 Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
5. 5 Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer: results for first 107 349 subjects. Lancet 1989; ii: 1160-64.
6. 6 Kewenter J, Björck S, Haglind E, et al. Screening and re-screening for colorectal cancer: a controlled trial of fecal occult blood testing in 27 700 subjects. Cancer 1988; 62: 645-51.
7. 7 Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991; 1: 49-55.
8. 8 Kronborg O, Fenger C, Olsen J, Bech K, Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test: a prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989; 24: 599-606.
9. 9 Adamsen S, Kronborg O. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1984; 19: 431-34.
10. 10 Taylor WF, Fantana RS. Biometric design of the Mayo lung project for early detection and localization of bronchogenic carcinoma. Cancer 1972; 30: 1344-47.
11. 11 Kronborg O, Fenger C, Worm J, et al. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1992; 27: 47-52.
12. 12 Bech K, Kronborg O, Fenger C. Adenoma and hyperplastic polyps in screening studies. World J Surg 1991; 15: 7-13.
13. 13 Klaaborg K, Madsen MS, Søndergaard O, Kronborg O. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1986; 21: 1180-84.